Toronto, Ontario--(Newsfile Corp. - October 24, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, announces it has filed an amended and restated business acquisition report dated October 24, 2025 (the "Amended BAR"), relating to HEALWELL's acquisition of Orion Health Holdings Limited which closed on April 1, 2025. The Amended BAR replaces and supersedes the previous business acquisition report of HEALWELL filed on June 30, 2025.
The Company filed the Amended BAR to update the audit report to reflect an administrative change that the audit report is prepared in compliance with the International Standards on Auditing ("ISA") whereas the prior report reflected compliance with ISA (New Zealand) ("ISA NZ"). Although ISA NZ is substantively similar to ISA, the audit report has been updated to confirm compliance with ISA and include additional disclosure related to the auditor's responsibilities in connection with the audit as required by ISA. The Amended BAR was filed at the request of staff of the Ontario Securities Commission in connection with a staff review.
The Amended BAR can be viewed on SEDAR+ at www.sedarplus.ca.
James Lee
Chief Executive Officer
HEALWELL AI Inc.
About HEALWELL AI
HEALWELL is a healthcare artificial intelligence company focused on preventative care. Its mission is to improve healthcare and save lives through early identification and detection of disease. Using its own proprietary technology, the Company is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases, improve efficiency of their practice and ultimately help improve patient health outcomes. HEALWELL is executing a strategy centered around developing and acquiring technology and clinical sciences capabilities that complement the Company's road map. HEALWELL is publicly traded on the Toronto Stock Exchange under the symbol "AIDX" and on the OTC Exchange under the symbol "HWAIF". To learn more about HEALWELL, please visit https://healwell.ai/.
For more information:
Pardeep S. Sangha
Investor Relations, HEALWELL AI Inc.
Phone: 604-572-6392
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | C$0.95 |
| Daily Change: | -0.02 -2.06 |
| Daily Volume: | 419,400 |
| Market Cap: | C$264.480M |
November 06, 2025 November 03, 2025 September 25, 2025 | |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
